Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship

[41] van Leeuwen-Stok E(2005)Male breast cancer incidence among atomic bomb survivors J Natl Cancer Inst. 97 603-164

[42] Porter P(2017)Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors - differences in excess relative and absolute risk from female breast cancer Environ Health Perspect. 125 223-ee9

[43] Atlas CG(1994)Ionizing radiation and breast cancer in men (United States) Cancer Causes Control. 5 9-711

[44] N. S(2017)Olaparib for metastatic breast cancer in patients with a germline BRCA mutation N Engl J Med. 377 523-291

[45] Ghani M(2016)Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review Am J Surg. 212 660-917

[46] Sochat J(2010)Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA. 304 967-874

[47] Luo Y(2001)Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers J Natl Cancer Inst. 93 1633-1863

[48] Tao F(2004)Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol. 22 1055-1332

[49] Ademuyiwa A(2001)Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med. 345 159-89

[50] Esposito E(2021)Male breast cancer risk assessment and screening recommendations in high-risk men who undergo genetic counseling and multigene panel testing Clin Breast Cancer. 21 e74-203

[41] van Leeuwen-Stok E(2005)Male breast cancer incidence among atomic bomb survivors J Natl Cancer Inst. 97 603-164

[42] Porter P(2017)Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors - differences in excess relative and absolute risk from female breast cancer Environ Health Perspect. 125 223-ee9

[43] Atlas CG(1994)Ionizing radiation and breast cancer in men (United States) Cancer Causes Control. 5 9-711

[44] N. S(2017)Olaparib for metastatic breast cancer in patients with a germline BRCA mutation N Engl J Med. 377 523-291

[45] Ghani M(2016)Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review Am J Surg. 212 660-917

[46] Sochat J(2010)Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA. 304 967-874

[47] Luo Y(2001)Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers J Natl Cancer Inst. 93 1633-1863

[48] Tao F(2004)Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol. 22 1055-1332

[49] Ademuyiwa A(2001)Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med. 345 159-89

[50] Esposito E(2021)Male breast cancer risk assessment and screening recommendations in high-risk men who undergo genetic counseling and multigene panel testing Clin Breast Cancer. 21 e74-203